Target intelligence / Profile preview

Pre-mRNA-splicing factor SYF1 (XAB2)

Target
XAB2
Molecular classification
Other (Multifunctional protein, splicing factor, DNA repair-associated protein)
01

Overview

Pre-mRNA-splicing factor SYF1 (XAB2) is a conserved, multifunctional nuclear protein of approximately 100 kDa, featuring 15 tetratricopeptide repeat (TPR) motifs that mediate protein–protein interactions[1][2]. XAB2 participates in several essential processes: it is a component of the Prp19/XAB2 complex required for pre-mRNA splicing; it plays a critical, specific role in transcription-coupled nucleotide excision repair (TC-NER), especially for RNA polymerase II-transcribed genes[1][2][3]. It also regulates transcription of certain genes (e.g., CENPE, contributing to cell cycle progression), mRNA export, and homologous recombination repair[1][2][3]. Loss of XAB2 results in impaired splicing, defective TC-NER, genome instability, mitotic arrest, and cell death[1][2]. The protein is implicated in cancer biology due to its essential roles in DNA repair and genome stability, and is crucial for early embryogenesis[1][2][3]. No clinically approved drugs or specific small molecules are known to target XAB2 directly, and no validated biomarkers or mechanisms of drug action specific to XAB2 have been described in the literature[1][2][3]. Note: XAB2 is not a classical therapeutic target (e.g. receptor, enzyme, or transporter) but rather a multifunctional splicing and DNA repair factor necessary for cell viability and genome integrity[1][2][3].

Other names
Pre-mRNA-splicing factor SYF1XAB2XPA-binding protein 2SYF1 homologHCNPKIAA1177HCRNPP3898NTC90crn-related protein kim1
02

Biological functions

Pre-mRNA splicingTranscription regulationTranscription-coupled nucleotide excision repair (TC-NER)mRNA exportHomologous recombination (HR) in DNA repairMaintenance of genome stabilityRegulation of mitotic cell cycle progression
03

Disease associations

Cancer (genomic instability and DNA repair defects can contribute to tumorigenesis)Other (disruption of DNA repair and cell cycle may be implicated in additional disorders)
04

Safety considerations

Essential for early embryonic development (knockout leads to lethality)Potential risk of genome instability if inhibited

Beyond the preview

Go deeper on Pre-mRNA-splicing factor SYF1 (XAB2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pre-mRNA-splicing factor SYF1 (XAB2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call